News
Neurosurgeon Dr. Ben Rapoport, the cofounder of Precision Neuroscience, debunks the biggest misconception about invasive ...
StockStory.org on MSN5d
The 5 Most Interesting Analyst Questions From Jazz Pharmaceuticals’s Q1 Earnings CallJazz Pharmaceuticals faced a challenging first quarter as revenue remained flat year over year, missing Wall Street expectations. Management attributed the performance to contrasting trends across its ...
To meet this growing demand, we are proud to offer a series of high-quality Tau-related products to support researchers studying neurodegenerative diseases. Tau Protein: We offer full-length Tau, ...
Nevertheless, in the near term Shire's neuroscience products will remain highly profitable, and Vyvanse is still forecast to be its top seller in 2022, ...
These products offer a reliable, scalable, and regulatory-compliant solution for various stages of therapy development, from preclinical research to commercial production. Designed for Seamless ...
Medtronic said steady demand for its cardiovascular and neuroscience products boosted revenue in its fiscal third quarter, though the top line was below analyst forecasts. The medical-technology ...
Alkermes has a portfolio of commercialized neuroscience products and a pipeline that spans both neuroscience and cancer. The drugmaker is now exploring the possibility of splitting off its cancer ...
30-Second Brain applies this fun approach to more than 50 topics in neuroscience (my other contributions cover topics such as mirror neurons and the left-brain right-brain myth). In the publisher ...
In recent years, the integration of neuroscience principles into business practices has gained significant attention due to its remarkable results. For example, companies that adopt neuroscience ...
GeneSight is Myriad’s first offering in the neuroscience market, which according to the company consisted of more than 76 million people and $150 billion of healthcare spending in the U.S.
--BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results